Hepatic Stabilin-2 Mechanisms of Clearance

肝脏 Stabilin-2 清除机制

基本信息

  • 批准号:
    9330181
  • 负责人:
  • 金额:
    $ 22.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

ABSTRACT The human liver scavenges extracellular matrix material, including hyaluronic acid, chondroitin sulfate, and dead red blood cells, from circulation, in addition to serving as a metabolic power house. This scavenging activity is performed by liver sinusoidal endothelial cells (LSECs) expressing the Stabilin-2 receptor. Upon activation by a subset of ligands, Stabilin-2 induces the MAP kinase and NF-kB pathways, by which all LSECs "sense" their environment and reciprocate using small molecules like nitric oxide. LSECs serve as the interface between the blood and hepatocytes and contain fenestrae (sieve plates) that regulate macromolecules perfusing through to the hepatocytes. Damage of LSECs often reduces the number and size of the fenestrae, affecting overall liver metabolism. Liver diseases, such as fatty liver, affect more than a third of the adult population, and these diseases directly affect the scavenger/sensing capacity of LSECs. Damaged LSECs lead to a build-up of extracellular matrix material in the blood that then negatively affects kidney function. The liver clears dead cells from blood, but it is also a site for metastatic cancer, both of which are intimately related to the health of LSECs. To more fully understand the clearance role of LSECs, the project leader proposes to examine them under shear stress conditions that mimic conditions in the hepatic sinusoid. This study will be the first time that the clearance activity of LSECs has been examined under variant flow to assess activity of Stabilin-2 as the major receptor. Questions to be addressed include: What effect does shear stress have on simple ligands or complex ligands like pericellular HA coated cells? How do LSECs respond to their ligands during shear stress, and what effect does fatty liver, a common ailment, have on LSEC Stabilin-2-mediated endocytosis? From his previous studies with Stabilin-2, the project leader hypothesizes that specific ligand binding to Stabilin-2 by circulating hyaluronan-rich cells is enhanced under shear stress, allowing them to cease circulation and proliferate in liver, and that expression levels of Stabilin-2 directly correlates with liver clearance function. The central hypothesis of the proposed research is that ligand-Stabilin-2 interactions, followed by endocytosis and activation of cell signaling, are influenced by shear stress at the sinusoids and hepatic metabolic status (e.g., fatty liver), which affects blood clearance and cancer cell metastasis to liver. The project leader will test this hypothesis using stable recombinant cells and primary LSECs from normal and disease models of rat livers. Purified LSECs from these livers will be evaluated under flow cell culture conditions to monitor ligand binding and signaling events propagated by Stabilin-2. To accomplish the project goal, the project leader will pursue three specific aims: 1) Determine Stabilin-2 binding of ligands under flow conditions, 2) Determine the effects of shear stress on cellular signaling in LSECs, and 3) Determine Stabilin-2 expression and endocytic activity in normal and fatty liver.
摘要 人肝脏清除细胞外基质材料,包括透明质酸、硫酸软骨素和胶原蛋白。 死亡的红细胞,从循环,除了作为一个代谢动力室。这种拾荒行为 活性由表达稳定蛋白-2受体的肝窦内皮细胞(LSEC)进行。后 稳定蛋白-2通过一系列配体激活,诱导MAP激酶和NF-kB通路,所有LSEC "感知"环境,并利用一氧化氮等小分子进行互动。LSEC充当接口 在血液和肝细胞之间,含有调节大分子的窗孔(筛板) 灌注到肝细胞。LSEC的损伤通常会减少窗孔的数量和大小, 影响整个肝脏代谢肝脏疾病,如脂肪肝,影响超过三分之一的成年人, 这些疾病直接影响LSEC的清除/传感能力。损坏的LSEC 导致细胞外基质物质在血液中积聚,然后对肾功能产生负面影响。的 肝脏清除血液中的死细胞,但它也是转移性癌症的一个部位,两者密切相关 对LSEC的健康至关重要。为了更充分地了解LSEC的清除作用,项目负责人建议 在模拟肝窦的剪切应力条件下检查它们。本研究将 这是第一次在不同流量下审查LSEC的清除活动,以评估 稳定素-2作为主要受体。需要解决的问题包括:剪切应力对 简单配体或复杂配体,如细胞周HA包被细胞?LSEC如何对它们的配体做出反应 以及脂肪肝这种常见疾病对LSEC Stabilin-2介导的 内吞作用?根据他以前对稳定蛋白-2的研究,项目负责人假设特定的配体 在剪切应力下,循环中富含透明质酸的细胞与稳定蛋白-2的结合增强,使它们能够 在肝脏中停止循环和增殖,稳定蛋白-2的表达水平与肝脏 清除功能这项研究的中心假设是,配体-稳定蛋白-2相互作用, 随后是胞吞作用和细胞信号传导的激活,受到窦状隙处的剪切应力的影响, 肝代谢状态(例如,脂肪肝),其影响血液清除和癌细胞转移到肝脏。 项目负责人将使用稳定的重组细胞和来自正常和 大鼠肝脏疾病模型。将在流动细胞培养下评价来自这些肝脏的纯化LSEC 条件以监测由稳定蛋白-2传播的配体结合和信号传导事件。为实现项目 为了实现这一目标,项目负责人将追求三个具体目标:1)确定稳定蛋白-2结合的配体下流动 2)确定剪切应力对LSEC中细胞信号传导的影响,和3)确定稳定蛋白-2 在正常和脂肪肝中的表达和内吞活性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDWARD N HARRIS其他文献

EDWARD N HARRIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDWARD N HARRIS', 18)}}的其他基金

Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10806783
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10689248
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10501862
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
Liver-Mediated Clearance of Low Molecular Weight Heparins
肝脏介导的低分子量肝素清除率
  • 批准号:
    9241420
  • 财政年份:
    2016
  • 资助金额:
    $ 22.12万
  • 项目类别:
SPLICE VARIANTS OF THE HA RECEPTOR FOR ENDOCYTOSIS
用于内吞作用的 HA 受体的剪接变体
  • 批准号:
    6936749
  • 财政年份:
    2005
  • 资助金额:
    $ 22.12万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 22.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了